The Lancet Neurology in conversation with
A podcast by The Lancet Group - Thursdays
187 Episodes
-  Giuseppe Citerio on frailty and TBIPublished: 19/01/2022
-  Alberto Costa on memantine in adolescents and young adults with Down syndromePublished: 20/12/2021
-  Olivier Rascol on amantadine for patients with movement disordersPublished: 17/11/2021
-  Antonio Uccelli on stems cells for MSPublished: 20/10/2021
-  Priya Palta on blood pressure control and cognitive declinePublished: 15/09/2021
-  Adam Boxer on tau biomarkersPublished: 18/08/2021
-  Irene Cortese on the difficulties of designing clinical trialsPublished: 21/07/2021
-  Doug Turnbull on mitochondrial diseases in adultsPublished: 16/06/2021
-  Geert Jan Biessels on predicting post-stroke cognitive impairmentPublished: 19/05/2021
-  Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALSPublished: 21/04/2021
-  Anne MacGregor on menstrual migrainePublished: 17/03/2021
-  Peter Rothwell on asymptomatic carotid stenosis and strokePublished: 17/02/2021
-  Spinal cord injury and degenerative cervical myelopathyPublished: 20/01/2021
-  Genetic risk factors for sCJDPublished: 22/12/2020
-  Prednisone in short-term prevention of cluster headachePublished: 24/11/2020
-  PET imaging of inflammation in neurological and psychiatric disordersPublished: 21/10/2020
-  Neurological associations of COVID-19Published: 4/09/2020
-  Advances in understanding of Rett syndromePublished: 31/07/2020
-  Management of Parkinson's diseasePublished: 17/06/2020
-  Optimal time to treat Huntington's DiseasePublished: 26/05/2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.
